MLB: No Tejada Biogenesis violation
Major League Baseball said Wednesday that it investigated Miguel Tejada as part of its Biogenesis probe and found no violation by the Kansas City infielder.
"The Office of the Commissioner investigated all allegations regarding players associated with Anthony Bosch and Biogenesis," MLB said in a statement. "The investigation found no violation by Miguel Tejada of the Joint Drug Prevention and Treatment Program."
ESPN's "Outside The Lines" reported Tuesday that Tejada, suspended for 105 games last week because of positive tests for amphetamine use, also was implicated in the Biogenesis investigation. OTL reported that baseball officials had the choice of going after Tejada for his involvement with Biogenesis or because of his amphetamine use. It chose the latter. It is the third time Tejada has tested positive for amphetamines.
OTL, citing sources, reported that Biogenesis founder Bosch provided evidence that Tejada had been a customer of his clinic.
Tejada said he had a therapeutic use exemption for the drug Adderall, which expired in April. The MLB Players Association argued that Tejada should have been allowed to play while seeking an extension. Baseball disagreed, and Tejada did not fight the suspension.
Tejada, 39, was the American League MVP in 2002. He was hitting .288 with three home runs and 20 RBIs in 53 games for the Royals this season.